IBDEI1QH ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31038,1,3,0)
 ;;=3^Anogenital (Venereal) Warts
 ;;^UTILITY(U,$J,358.3,31038,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,31038,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,31039,0)
 ;;=B35.0^^190^1932^280
 ;;^UTILITY(U,$J,358.3,31039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31039,1,3,0)
 ;;=3^Tinea Barbae and Tinea Capitis
 ;;^UTILITY(U,$J,358.3,31039,1,4,0)
 ;;=4^B35.0
 ;;^UTILITY(U,$J,358.3,31039,2)
 ;;=^5000604
 ;;^UTILITY(U,$J,358.3,31040,0)
 ;;=B35.1^^190^1932^285
 ;;^UTILITY(U,$J,358.3,31040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31040,1,3,0)
 ;;=3^Tinea Unguium
 ;;^UTILITY(U,$J,358.3,31040,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,31040,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,31041,0)
 ;;=B35.6^^190^1932^282
 ;;^UTILITY(U,$J,358.3,31041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31041,1,3,0)
 ;;=3^Tinea Cruris
 ;;^UTILITY(U,$J,358.3,31041,1,4,0)
 ;;=4^B35.6
 ;;^UTILITY(U,$J,358.3,31041,2)
 ;;=^119711
 ;;^UTILITY(U,$J,358.3,31042,0)
 ;;=B35.3^^190^1932^284
 ;;^UTILITY(U,$J,358.3,31042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31042,1,3,0)
 ;;=3^Tinea Pedis
 ;;^UTILITY(U,$J,358.3,31042,1,4,0)
 ;;=4^B35.3
 ;;^UTILITY(U,$J,358.3,31042,2)
 ;;=^119732
 ;;^UTILITY(U,$J,358.3,31043,0)
 ;;=B35.5^^190^1932^283
 ;;^UTILITY(U,$J,358.3,31043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31043,1,3,0)
 ;;=3^Tinea Imbricata
 ;;^UTILITY(U,$J,358.3,31043,1,4,0)
 ;;=4^B35.5
 ;;^UTILITY(U,$J,358.3,31043,2)
 ;;=^119725
 ;;^UTILITY(U,$J,358.3,31044,0)
 ;;=B35.4^^190^1932^281
 ;;^UTILITY(U,$J,358.3,31044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31044,1,3,0)
 ;;=3^Tinea Corporis
 ;;^UTILITY(U,$J,358.3,31044,1,4,0)
 ;;=4^B35.4
 ;;^UTILITY(U,$J,358.3,31044,2)
 ;;=^119704
 ;;^UTILITY(U,$J,358.3,31045,0)
 ;;=B35.8^^190^1932^137
 ;;^UTILITY(U,$J,358.3,31045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31045,1,3,0)
 ;;=3^Dermatophytoses,Other
 ;;^UTILITY(U,$J,358.3,31045,1,4,0)
 ;;=4^B35.8
 ;;^UTILITY(U,$J,358.3,31045,2)
 ;;=^5000606
 ;;^UTILITY(U,$J,358.3,31046,0)
 ;;=B36.9^^190^1932^273
 ;;^UTILITY(U,$J,358.3,31046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31046,1,3,0)
 ;;=3^Superficial Mycosis,Unspec
 ;;^UTILITY(U,$J,358.3,31046,1,4,0)
 ;;=4^B36.9
 ;;^UTILITY(U,$J,358.3,31046,2)
 ;;=^5000611
 ;;^UTILITY(U,$J,358.3,31047,0)
 ;;=D69.0^^190^1932^32
 ;;^UTILITY(U,$J,358.3,31047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31047,1,3,0)
 ;;=3^Allergic Purpura
 ;;^UTILITY(U,$J,358.3,31047,1,4,0)
 ;;=4^D69.0
 ;;^UTILITY(U,$J,358.3,31047,2)
 ;;=^5002365
 ;;^UTILITY(U,$J,358.3,31048,0)
 ;;=B00.9^^190^1932^158
 ;;^UTILITY(U,$J,358.3,31048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31048,1,3,0)
 ;;=3^Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,31048,1,4,0)
 ;;=4^B00.9
 ;;^UTILITY(U,$J,358.3,31048,2)
 ;;=^5000480
 ;;^UTILITY(U,$J,358.3,31049,0)
 ;;=B02.9^^190^1932^292
 ;;^UTILITY(U,$J,358.3,31049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31049,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,31049,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,31049,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,31050,0)
 ;;=D17.9^^190^1932^89
 ;;^UTILITY(U,$J,358.3,31050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31050,1,3,0)
 ;;=3^Benign Lipomatous Neop,Unspec
 ;;^UTILITY(U,$J,358.3,31050,1,4,0)
 ;;=4^D17.9
 ;;^UTILITY(U,$J,358.3,31050,2)
 ;;=^5002020
 ;;^UTILITY(U,$J,358.3,31051,0)
 ;;=E08.621^^190^1932^134
 ;;^UTILITY(U,$J,358.3,31051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31051,1,3,0)
 ;;=3^DM d/t Underlying Condition w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,31051,1,4,0)
 ;;=4^E08.621
